SIMILAR PATTERNS OF AMINO ACIDS FOR 3QEO_A_LLTA261
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2a30 | DEOXYCYTIDINE KINASE (Homo sapiens) |
PF01712(dNK) | 5 | GLU A 53ARG A 128PHE A 137LEU A 141GLU A 197 | DCZ A 302 (-3.0A)DCZ A 302 (-4.1A)DCZ A 302 (-3.8A)NoneDCZ A 302 (-3.5A) | 0.97A | 3qeoA-2a30A:33.3 | 3qeoA-2a30A:92.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2a30 | DEOXYCYTIDINE KINASE (Homo sapiens) |
PF01712(dNK) | 5 | GLU A 53GLN A 97ARG A 128PHE A 137LEU A 141 | DCZ A 302 (-3.0A)DCZ A 302 (-3.2A)DCZ A 302 (-4.1A)DCZ A 302 (-3.8A)None | 0.97A | 3qeoA-2a30A:33.3 | 3qeoA-2a30A:92.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2a30 | DEOXYCYTIDINE KINASE (Homo sapiens) |
PF01712(dNK) | 5 | GLU A 53LEU A 82ARG A 128LEU A 141GLU A 197 | DCZ A 302 (-3.0A)DCZ A 302 ( 4.9A)DCZ A 302 (-4.1A)NoneDCZ A 302 (-3.5A) | 1.01A | 3qeoA-2a30A:33.3 | 3qeoA-2a30A:92.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2a30 | DEOXYCYTIDINE KINASE (Homo sapiens) |
PF01712(dNK) | 5 | GLU A 53LEU A 82GLN A 97ARG A 128LEU A 141 | DCZ A 302 (-3.0A)DCZ A 302 ( 4.9A)DCZ A 302 (-3.2A)DCZ A 302 (-4.1A)None | 1.00A | 3qeoA-2a30A:33.3 | 3qeoA-2a30A:92.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2a30 | DEOXYCYTIDINE KINASE (Homo sapiens) |
PF01712(dNK) | 5 | GLU A 53LEU A 82MET A 85ARG A 128LEU A 141 | DCZ A 302 (-3.0A)DCZ A 302 ( 4.9A)DCZ A 302 ( 4.3A)DCZ A 302 (-4.1A)None | 0.93A | 3qeoA-2a30A:33.3 | 3qeoA-2a30A:92.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b4e | CORONIN-1A (Mus musculus) |
PF00400(WD40)PF08953(DUF1899)PF16300(WD40_4) | 5 | VAL A 70LEU A 62MET A 47ARG A 29LEU A 340 | None | 1.31A | 3qeoA-2b4eA:0.0 | 3qeoA-2b4eA:21.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ocp | DEOXYGUANOSINEKINASE (Homo sapiens) |
PF01712(dNK) | 5 | GLN A 111ARG A 142PHE A 151LEU A 155GLU A 211 | DTP A 301 (-2.9A)DTP A 301 (-3.2A)DTP A 301 (-3.3A)NoneDTP A 301 (-3.5A) | 0.85A | 3qeoA-2ocpA:30.0 | 3qeoA-2ocpA:43.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ocp | DEOXYGUANOSINEKINASE (Homo sapiens) |
PF01712(dNK) | 5 | LEU A 96GLN A 111ARG A 142LEU A 155GLU A 211 | DTP A 301 (-4.6A)DTP A 301 (-2.9A)DTP A 301 (-3.2A)NoneDTP A 301 (-3.5A) | 0.78A | 3qeoA-2ocpA:30.0 | 3qeoA-2ocpA:43.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ocp | DEOXYGUANOSINEKINASE (Homo sapiens) |
PF01712(dNK) | 5 | LEU A 96MET A 99GLN A 111ARG A 142LEU A 155 | DTP A 301 (-4.6A)DTP A 301 ( 3.9A)DTP A 301 (-2.9A)DTP A 301 (-3.2A)None | 0.93A | 3qeoA-2ocpA:30.0 | 3qeoA-2ocpA:43.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pia | PHTHALATEDIOXYGENASEREDUCTASE (Burkholderiacepacia) |
PF00111(Fer2)PF00175(NAD_binding_1)PF00970(FAD_binding_6) | 5 | GLU A 136ARG A 139PHE A 114LEU A 116GLU A 40 | None | 0.91A | 3qeoA-2piaA:0.0 | 3qeoA-2piaA:20.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4a60 | FATTY ACID-BINDINGPROTEIN 9 TESTISLIPID-BINDINGPROTEIN, TLBP,TESTIS-TYPE FATTYACID-BINDINGPROTEIN, T-FABP (Homo sapiens) |
PF00061(Lipocalin) | 5 | GLU A 73LEU A 24MET A 21TYR A 20GLN A 59 | NoneNoneEDO A1134 (-4.5A)NoneEDO A1134 ( 3.9A) | 1.18A | 3qeoA-4a60A:0.0 | 3qeoA-4a60A:20.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bop | OTUDOMAIN-CONTAININGPROTEIN 1 (Homo sapiens) |
PF02338(OTU) | 5 | VAL A 329LEU A 388MET A 384LEU A 321GLU A 338 | None | 1.29A | 3qeoA-4bopA:0.0 | 3qeoA-4bopA:18.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4j7h | EVAA 2,3-DEHYDRATASE (Amycolatopsisorientalis) |
PF03559(Hexose_dehydrat) | 5 | VAL A 348LEU A 362GLN A 438PHE A 257GLU A 269 | None | 1.02A | 3qeoA-4j7hA:0.0 | 3qeoA-4j7hA:20.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nmy | ABC-TYPE TRANSPORTSYSTEM,EXTRACELLULARSOLUTE-BINDINGPROTEIN (Clostridioidesdifficile) |
PF09084(NMT1) | 5 | VAL A 180LEU A 187TYR A 274PHE A 123GLU A 64 | NoneNoneNoneNoneVIB A 401 (-2.9A) | 1.37A | 3qeoA-4nmyA:0.0 | 3qeoA-4nmyA:21.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oua | LATENT FORM OF PPO4TYROSINASE (Agaricusbisporus) |
PF00264(Tyrosinase) | 5 | GLU B 218ARG B 481PHE B 482LEU B 504GLU B 212 | None | 1.23A | 3qeoA-4ouaB:undetectable | 3qeoA-4ouaB:19.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qpm | MITOTIC CHECKPOINTSERINE/THREONINE-PROTEIN KINASE BUB1 (Homo sapiens) |
PF00069(Pkinase) | 5 | VAL A1057LEU A1054GLN A 891LEU A 999GLU A1030 | None | 1.11A | 3qeoA-4qpmA:undetectable | 3qeoA-4qpmA:19.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4u0t | ADC-7 BETA-LACTAMASE (Acinetobacterbaumannii) |
PF00144(Beta-lactamase) | 5 | VAL A 353LEU A 333MET A 335TYR A 322LEU A 19 | None | 1.28A | 3qeoA-4u0tA:undetectable | 3qeoA-4u0tA:22.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b3h | PROTEIN SCARECROW (Arabidopsisthaliana) |
PF03514(GRAS) | 5 | GLU A 484VAL A 486LEU A 512ARG A 432LEU A 436 | None | 1.49A | 3qeoA-5b3hA:undetectable | 3qeoA-5b3hA:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ipy | FLAVIN-CONTAININGMONOOXYGENASE (Roseovariusnubinhibens) |
PF00743(FMO-like) | 5 | LEU A 380TYR A 376GLN A 17PHE A 311LEU A 313 | None | 1.47A | 3qeoA-5ipyA:1.4 | 3qeoA-5ipyA:20.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5u03 | CTP SYNTHASE 1 (Homo sapiens) |
PF00117(GATase)PF06418(CTP_synth_N) | 5 | GLU A 513VAL A 463LEU A 555TYR A 554PHE A 519 | None | 1.29A | 3qeoA-5u03A:5.2 | 3qeoA-5u03A:17.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6g2j | NADH DEHYDROGENASE[UBIQUINONE] 1 ALPHASUBCOMPLEX SUBUNIT10, MITOCHONDRIAL (Mus musculus) |
no annotation | 5 | GLU O 53LEU O 79GLN O 97ARG O 126GLU O 191 | ADP O 401 ( 4.7A)NoneADP O 401 (-3.5A)ADP O 401 ( 4.3A)ADP O 401 (-3.2A) | 1.23A | 3qeoA-6g2jO:undetectable | 3qeoA-6g2jO:11.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbh | HOPQ (Helicobacterpylori) |
no annotation | 5 | GLU C 357VAL C 380LEU C 89MET C 281GLU C 388 | None | 1.23A | 3qeoA-6gbhC:undetectable | 3qeoA-6gbhC:13.57 |